Stand For Health Freedom Issues OPEN LETTER To Tennessee Dept Of Health Officials About The Pushing Of Vaccines For Babies, Pregnant Women

Stand For Health Freedom Issues OPEN LETTER To Tennessee Dept Of Health Officials About The Pushing Of Vaccines For Babies, Pregnant Women

Stand For Health Freedom Issues OPEN LETTER To Tennessee Dept Of Health Officials About The Pushing Of Vaccines For Babies, Pregnant Women

Image Credit: Canva

The Tennessee Conservative Staff –

The Tennessee Director of Stand For Health Freedom has issued an open letter to Dr. Caitlin Newhouse, the Medical Director of the Vaccine-Preventable Diseases & Immunization Program in the Tennessee Department of Health.

The letter was also sent to Governor Bill Lee, Health Commissioner Dr. Ralph Alvarado, the Tennessee General Assembly, along with media outlets.

The letter’s text is copied below or the complete letter can be downloaded HERE.

OPEN LETTER to Dr. Caitlin Newhouse, Medical Director, Vaccine-Preventable Diseases & Immunization Program, Tennessee Department of Health

cc: Governor Bill Lee, Commissioner Dr. Ralph Alvarado, the General Assembly, TN Media Outlets

RE: Your September 26, 2024 “Dear Colleague” Letter to TN Healthcare Providers

Dear Dr. Newhouse:

In your September 26, 2024 TN Health Alert to Healthcare Providers1, you stated:

We encourage you to co-administer vaccines for eligible and interested patients, including RSV, COVID-19, and influenza.”

Your recommendation includes babies as young as six months old and pregnant women. You link the Center for Disease Control & Prevention (CDC) web pages throughout your letter, but you fail to directly provide any evidence for the safety of your recommendation. The public’s trust in the CDC has been plummeting. In order for Tennesseans to be able to trust the healthcare providers who follow your advice, please provide the following in a publicly accessible “Dear Colleague” letter to all TN Healthcare Providers.

  1. All clinical trials on which your claims of safety are based for the co-administering of RSV, COVID-19, and influenza products to babies, pregnant women, and others.
  2. For each trial:
  • Whether or not the trial included enough participants to be considered sufficiently powered to reveal severe adverse reactions;
  • Whether or not the trial lasted long enough to inform about long-term safety issues;
  • The exclusion criteria and how those exclusions may impact trial results and whether the results can be generalized to the public.
  1. A summary of types and numbers of adverse reactions reported to the Vaccine Adverse Event Reporting Systems (VAERS) and MedWatch for:
  • Individually administered RSV, COVID-19, and influenza products.
  • Co-administered RSV, COVID-19, and influenza products.
  1. The states in the United States and the countries which no longer recommend COVID-19 vaccines for children, adolescents, young adults, pregnant women, or for anyone.
  2. Guidance for reporting adverse reactions and filing for compensation for injuries or death due to co-administration when each product has a different legal liability status2 for manufacturers and healthcare providers who administer them.

The public’s welfare is an urgent priority; please provide the requested information by November 1, 2024.

Sincerely,

Bernadette Pajer

TN Director of Stand for Health Freedom

1TNHAN+09.26.24+FINAL+Distributed-compressed.pdf

2https://www.hrsa.gov/vaccine-compensation/covered-vaccines ; RSV products not covered under VICP or CICP.

Share this:

Leave a Reply